HIF1A and colorectal carcinoma: Recent findings suggest HIF‐1α shifts CRC metabolic processes toward glycolysis and the pentose phosphate pathway (PPP), impacting glucose and lactate utilization in the context of PI3K/AKT and β‐catenin signaling, and increasing CRC sensitivity to 5‐fluorouracil (5‐FU) [95].